CLINICAL_TRIALS
trial_result
· 2014-07-10
Clinical Trial Update: Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706) [Phase 3]
Summary
A Phase 3 clinical trial assessing the safety and effectiveness of esmirtazapine for chronic primary insomnia has completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Insomnia | Phase 3 | Status: COMPLETED | Results posted: 2014-07-10